Takeaway
Individuals with pediatric-onset multiple sclerosis (POMS) took longer to reach disability milestones but reached them at a younger age than individuals with adult-onset multiple sclerosis (AOMS).
Why this matters
While POMS develops in a minority of individuals, implementing a disease modifying treatment (DMT) strategy early after diagnosis can decrease the risk of disability progression over time.